DNM1L and Hyperglycemia: Drp1 inhibitor, mitochondrial division inhibitor 1 (Mdivi-1), prevented hyperglycemia-induced cardiomyocyte hypertrophy by reducing phosphorylation of Drp1 at serine 616 (S616) and inducing phosphorylation at serine 637 (S637).